This prospective cohort study evaluated 106,542 participants enrolled in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. The investigation tracked individuals over a follow-up period of 8.8 years to assess dietary patterns and disease outcomes. Data collection occurred within the trial setting.
Researchers examined the Planetary Health Diet Index as the primary exposure. The highest quartile of this index demonstrated a 29% lower risk of lung cancer incidence compared to the lowest quartile. The hazard ratio was 0.71 with a 95% CI of 0.62, 0.81. Statistical analysis showed a P trend < 0.001 for the primary outcome. Results indicated a significant inverse relationship.
Secondary outcomes included non-small cell lung cancer and small cell lung cancer. An inverse association was observed for non-small cell lung cancer with a P non-linear value of 0.035. Small cell lung cancer analysis yielded a P non-linear value of 0.956. Safety data regarding adverse events, serious adverse events, and discontinuations were not reported. Tolerability information was also not reported.
The authors noted that findings remained stable following multiple sensitivity analyses. This evidence supports the potential of the Planetary Health Diet as a dietary strategy for lung cancer prevention. However, the observational nature of the study indicates an association rather than causality. Clinicians should interpret these results as hypothesis-generating.
View Original Abstract ↓
BackgroundThe Planetary Health Diet Index (PHDI) is a validated tool for assessing adherence to the Planetary Health Diet (PHD)—a dietary pattern designed to address both human wellness and environmental sustainability. However, limited studies have specifically investigated the association between PHDI and lung cancer susceptibility—a leading global cancer mortality cause. Our study intends to explore this potential association.MethodsData for this analysis were derived from the prospective cohort of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. The PHDI was calculated for each participant to quantify their adherence to the target dietary pattern. Cox proportional hazards regression models were applied to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between PHDI and the incidence of lung cancer and its distinct subtypes. Subgroup analyses were conducted to identify potential effect modifiers that might influence the observed association, while sensitivity analyses were performed to verify the robustness and stability of the study findings.ResultsOver a follow-up period of 8.8 years, 1,846 lung cancer cases were identified among 106,542 participants. In the fully adjusted model, participants in the highest quartile (Quartile 4) of the PHDI had a 29% lower lung cancer risk compared to those in the lowest quartile (Quartile 1) (HR Quartile 4 vs Quartile 1: 0.71, 95% CI: 0.62, 0.81; P trend < 0.001). This inverse association was consistent across both non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Restricted cubic spline plots revealed a non-linear inverse dose–response relationship between PHDI and lung cancer risk (P non-linear: 0.043) as well as NSCLC risk (P non-linear: 0.035), whereas a linear inverse association was observed for SCLC (P non-linear: 0.956). No significant effect modification was detected in subgroup analyses, and the core findings remained stable and reliable following multiple sensitivity analyses.ConclusionOur findings suggest that higher PHDI is inversely associated with lung cancer risk and its subtypes (NSCLC and SCLC), supporting the potential of PHD as a dietary strategy for lung cancer prevention.